These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15372603)

  • 1. Cigarette smoking in Parkinson's disease: influence on disease progression.
    Alves G; Kurz M; Lie SA; Larsen JP
    Mov Disord; 2004 Sep; 19(9):1087-1092. PubMed ID: 15372603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and cognitive function in Parkinson's disease.
    Weisskopf MG; Grodstein F; Ascherio A
    Mov Disord; 2007 Apr; 22(5):660-5. PubMed ID: 17266085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cigarette smoking and Parkinson's disease: a population based case-control study].
    Dong JQ; Zhang QH; Jiang ZX; Yi ZY; Yu L; Li ZH; Zhang YQ; Fang MJ; Zhang ZX; Zhang KL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):604-7. PubMed ID: 12975019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk.
    Powers KM; Kay DM; Factor SA; Zabetian CP; Higgins DS; Samii A; Nutt JG; Griffith A; Leis B; Roberts JW; Martinez ED; Montimurro JS; Checkoway H; Payami H
    Mov Disord; 2008 Jan; 23(1):88-95. PubMed ID: 17987647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smokeless tobacco use and the risk of Parkinson's disease mortality.
    O'Reilly EJ; McCullough ML; Chao A; Henley SJ; Calle EE; Thun MJ; Ascherio A
    Mov Disord; 2005 Oct; 20(10):1383-4. PubMed ID: 16007624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease.
    De Reuck J; De Weweire M; Van Maele G; Santens P
    J Neurol Sci; 2005 Apr; 231(1-2):35-9. PubMed ID: 15792818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease, stroke, and related epidemiology.
    Nataraj A; Rajput AH
    Mov Disord; 2005 Nov; 20(11):1476-80. PubMed ID: 16037918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of depression on motor function and disease severity of Parkinson's disease.
    Papapetropoulos S; Ellul J; Argyriou AA; Chroni E; Lekka NP
    Clin Neurol Neurosurg; 2006 Jul; 108(5):465-9. PubMed ID: 16150537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and Parkinson's disease.
    Mayeux R; Tang MX; Marder K; Côté LJ; Stern Y
    Mov Disord; 1994 Mar; 9(2):207-12. PubMed ID: 8196685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cigarette smoking and Parkinson's disease: a case-control study in a population characterized by a high prevalence of pesticide exposure.
    Galanaud JP; Elbaz A; Clavel J; Vidal JS; Corrèze JR; Alpérovitch A; Tzourio C
    Mov Disord; 2005 Feb; 20(2):181-9. PubMed ID: 15468111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and correlates of neuropsychiatric symptoms in a population with Parkinson's disease in Mexico.
    Ringman JM; Diaz-Olavarrieta C; Rodriguez Y; Fairbanks L; Cummings JL
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):99-105. PubMed ID: 12050472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cigarette smoking, tea, and coffee consumption on the progression of Parkinson's disease.
    Kandinov B; Giladi N; Korczyn AD
    Parkinsonism Relat Disord; 2007 May; 13(4):243-5. PubMed ID: 17275394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of clinical progression in Parkinson's disease. A prospective study.
    Schrag A; Dodel R; Spottke A; Bornschein B; Siebert U; Quinn NP
    Mov Disord; 2007 May; 22(7):938-45. PubMed ID: 17415791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Parkinson's disease and other types of Parkinsonism. A door-to-door survey in Bidasoa, Spain.
    Bergareche A; De La Puente E; López de Munain A; Sarasqueta C; de Arce A; Poza JJ; Martí-Massó JF
    J Neurol; 2004 Mar; 251(3):340-5. PubMed ID: 15015016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy.
    Nuti A; Ceravolo R; Dell'Agnello G; Gambaccini G; Bellini G; Kiferle L; Rossi C; Logi C; Bonuccelli U
    Parkinsonism Relat Disord; 2004 Dec; 10(8):481-5. PubMed ID: 15542008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female gender but not cigarette smoking delays the onset of Parkinson's disease.
    Martínez-Rumayor A; Arrieta O; Sotelo J; García E
    Clin Neurol Neurosurg; 2009 Nov; 111(9):738-41. PubMed ID: 19695769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.
    Janvin CC; Larsen JP; Aarsland D; Hugdahl K
    Mov Disord; 2006 Sep; 21(9):1343-9. PubMed ID: 16721732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anomalies of asymmetry of clinical signs in parkinsonism.
    Toth C; Rajput M; Rajput AH
    Mov Disord; 2004 Feb; 19(2):151-7. PubMed ID: 14978669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.